Literature DB >> 32008791

Trends in the surgical management of malignant ovarian germcell tumors.

Dimitrios Nasioudis1, Spyridon A Mastroyannis2, Nawar A Latif2, Emily M Ko2.   

Abstract

OBJECTIVE: To evaluate trends in the surgical management of young women and pediatric patients with malignant ovarian germ cell tumors (MOGCTs) and associated survival outcomes.
MATERIALS AND METHODS: Using the Surveillance, Epidemiology, and End Results database we identified patients under 40 years who underwent surgery between 1994 and 2014. The Joinpoint Regression Program was employed to investigate the presence of temporal trends and calculate average annual percent change (AAPC) rates. For analysis purposes two age groups were formed; pediatric/adolescent (≤21 yrs) and young adult (22-40 yrs). Histology was categorized into dysgerminoma, immature teratoma, yolk-sac tumor, mixed germ cell tumor and other histology. Cancer specific survival was compared using log-rank tests.
RESULTS: A total of 2238 patients were identified, with median age 21 years. Only 12.4% underwent hysterectomy. One third underwent omentectomy, and one half underwent lymphadenectomy (LND). A decrease in the rate of omentectomy (AAPC: -2.15, 95% CI: -3.4, -0.9) and hysterectomy (AAPC: -3.31, 95% CI: -6.1, -0.4) was observed. There was no change in the rate of LND (AAPC: 0.17, 95% CI: -0.7, 1.1). Pediatric patients were less likely to undergo omentectomy (30.2% vs 35.5%, p < 0.001), hysterectomy (3.5% vs 22%, p < 0.001) and LND (45.6% vs 54.7%, p < 0.001). There were no apparent survival differences according to the performance of hysterectomy, omentectomy or LND, when stratified by early (stage I) and advanced stage (II-IV), (p > 0.05).
CONCLUSIONS: Pediatric patients with MOGCTs undergo less extensive surgical staging. A trend towards less extensive surgical procedures for young women over time was observed, without an apparent detrimental effect on cancer specific survival.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dysgerminoma; Germ cell tumor; Ovary

Mesh:

Year:  2020        PMID: 32008791     DOI: 10.1016/j.ygyno.2020.01.033

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.

Authors:  Jieyu Wang; Ruifang Chen; Jun Li; Xin Lu
Journal:  Arch Gynecol Obstet       Date:  2020-09-04       Impact factor: 2.344

2.  Clinical outcome of lymphadenectomy in malignant ovarian germ cell tumors: a systematic review and meta-analysis.

Authors:  Ling Han; Yali Chen; Yana Liu; Ai Zheng; Hengxi Chen
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

3.  Pelvic masses after surgery for immature ovarian teratoma: A 10-year experience of Western China.

Authors:  Sixia Xie; Xibiao Jia; Tingting Li; Yuanyuan Xu; Weiwei Wu; Yichao Qiu; Shuang Yuan; Xue Peng; Hongjing Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.